Federal Circuit· 3/30/1998
In re Berg
Citations
- 140 F.3d 1428
- 46 U.S.P.Q. 2d (BNA) 1226
- 1998 U.S. App. LEXIS 6309
- 1998 WL 139543
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- affirming the rejection of genus claims in a later patent application for obviousness-type double patenting in light of species claims in an earlier patent
- performing the first step in the analysis only implicitly, and focusing instead on the question of what test applied to the determination of whether the claims of the two patents were “patentably distinct”
- the one-way test applies where the applicant could have filed both sets of claims in one application
- under a one-way test, “[i]f the application claim is not patentably distinct,” it cannot overcome a double-patenting rejection in the absence of a terminal disclaimer
- “The invention described in claim 1 of the ’916 patent ... is anything but ‘totally separate’ from that of the Berg application,” where “the specifications of the Berg application and of the ’916 patent are identical; the two disclosures are almost exactly alike”
Source: CourtListener parenthetical corpus (CC0).
Judges: Clevenger, Gajarsa, Michel
Read full opinion on CourtListenerCited by
19 cases in this archive cite this case.
- Abbott Laboratories and Mitsubishi-Tokyo Pharmaceuticals, Inc. (Formerly Known as Tokyo Tanabe Co., Ltd.) v. Dey, L.P. And Dey, Inc.Federal Circuit· 2002-06-14· cited 41×
- Eli Lilly And Company v. Barr Laboratories, Inc.Federal Circuit· 2001-05-30· cited 38×
- AbbVie Inc. v. Mathilda & Terrance Kennedy Institute of Rheumatology TrustFederal Circuit· 2014-08-21· cited 31×
- In Re HubbellFederal Circuit· 2013-03-07· cited 21×
- In Re FallauxFederal Circuit· 2009-05-06· cited 19×
- Bristol-Myers Squibb Company, and Research Corporation Technologies, Inc. v. Pharmachemie B.V.Federal Circuit· 2004-04-21· cited 14×
- Eli Lilly & Co. v. Zenith Goldline Pharmaceuticals, Inc.S.D. Indiana· 2005-04-14· cited 14×
- Eli Lilly & Co. v. Barr Laboratories, Inc.Federal Circuit· 2001-05-30· cited 13×
- In Re Basell Poliolefine Italia S.P.A.Federal Circuit· 2008-11-13· cited 11×
- Amgen, Inc. v. F. Hoffmann-La Roche Ltd.D. Massachusetts· 2008-10-02· cited 8×
- Engineered Products Co. v. Donaldson Co., Inc.N.D. Iowa· 2002-09-30· cited 6×
- Novartis AG, Novartis Pharm. Corp. v. Ezra Ventures LLCFederal Circuit· 2018-12-07· cited 6×
- Geneva Pharmaceuticals, Inc. v. Glaxosmithkline PLCE.D. Virginia· 2002-02-25· cited 3×
- Purdue Pharma L.P. v. Collegium Pharm., Inc.District of Columbia· 2018-09-28· cited 3×
- Eli Lilly And Company v. Barr Laboratories, Inc.Federal Circuit· 2000-08-09· cited 2×
- Eli Lilly & Co. v. Barr Laboratories, Inc.Federal Circuit· 2000-08-09· cited 2×
- Calabrese v. Square D Co.N.D. Illinois· 1998-08-05· cited 1×
- Johnson Electric Industrial Manufacturing, Ltd. v. Ametek, Inc.D. Connecticut· 2006-08-24· cited 1×
- Janssen Biotech, Inc. v. Celltrion Healthcare Co.D. Massachusetts· 2016-09-29
Cites
6 cases in this archive are cited by this case.
- In Re Robert Goodman, Vic C. Knauf, Catherine M. Houch and Luca ComaiFederal Circuit· 1993-12-03· cited 85×
- General Foods Corporation v. Studiengesellschaft Kohle MbhFederal Circuit· 1992-10-02· cited 61×
- In Re Josephus J.M. BraatFederal Circuit· 1991-06-28· cited 24×
- In Re Jack Emert and Robert D. LundbergFederal Circuit· 1997-09-18· cited 23×
- Application of John E. BorahCustoms and Patent Appeals· 1966-01-06· cited 16×
- In re CalvertCustoms and Patent Appeals· 1938-06-27· cited 5×
Sourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.